Mhc-mediated toxic conjugates useful in ameliorating...

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

167/129, 530/15.

C07K 14/74 (2006.01) A61K 39/00 (2006.01) A61K 39/385 (2006.01) A61K 47/48 (2006.01) A61K 51/12 (2006.01) C07K 14/78 (2006.01)

Patent

CA 1340327

The invention is directed to methods and material useful in treating autoimmune diseases. The therapeutic agents are of the formula X1MHC2peptide or MHC2peptide1X wherein X represents a functional moiety selected from a toxin and a labeling group; MHC is an effective portion of the MHC glycoprotein, said glycoprotein dissociated from the cell surface on which it normally resides; and "peptide" represents an antigenic peptide sequence associated with an autoantigen; 1 represents a covalent bond or a linker bound to X and MHC or to X and peptide by covalent bonds; and 2 represents a covalent bond, a noncovalent association, or a linker covalently bound to or associated with the MHC and peptide. These complexes can be used to target helper T-cells which are specifically immunoreactive with autoantigens.

603841

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Mhc-mediated toxic conjugates useful in ameliorating... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mhc-mediated toxic conjugates useful in ameliorating..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mhc-mediated toxic conjugates useful in ameliorating... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1320870

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.